SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-21-035545
Filing Date
2021-07-02
Accepted
2021-07-02 16:05:21
Documents
5
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2020a1_aditxtherap.htm 10-K/A 50068
2 CERTIFICATION f10k2020a1ex31-1_aditx.htm EX-31.1 9516
3 CERTIFICATION f10k2020a1ex31-2_aditx.htm EX-31.2 9571
4 CERTIFICATION f10k2020a1ex31-3_aditx.htm EX-31.3 9512
5 CERTIFICATION f10k2020a1ex32-1_aditx.htm EX-32.1 5240
  Complete submission text file 0001213900-21-035545.txt   85032
Mailing Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043
Business Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043 909-488-0844
Aditx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39336 | Film No.: 211069937
SIC: 2834 Pharmaceutical Preparations